Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia

Hypersplenism and thrombocytopenia are common complications of liver cirrhosis or thalassemia, but current treatment strategies are limited. This study aimed to evaluate the efficacy and safety of thalidomide in the treatment of hypersplenism and thrombocytopenia in patients with liver cirrhosis or...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Chen, Yaocheng, Cai, Ning, Lai, Yongrong, Xu, Weiwei, Li, Jinyan, Huang, Lan, Huang, Ying, Hu, Meiling, Yang, Huangju, Chen, Jiangming
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7394185/
https://ncbi.nlm.nih.gov/pubmed/32792958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01137
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky